Federal Updates:HELP Copays Act: S. 1375, the Senate version of the HELP Copays Act currently has twelve cosponsors, and HR 830, the House version of the bill, has 56 cosponsors. The All…
Peggy, a longtime community member shares her family's history of involvement and advocacy. To learn more about Peggy's involvement in the bleeding disorders community watch the full interview or read the transcript below.
Can…
The U.S. Food and Drug Administration (FDA) has approved Opill (norgestrel), the first daily oral contraceptive approved for use in the U.S. without a prescription.
According to a new FDA news release, this approval will allow consumers to…
Hemophilia of Georgia (HoG) celebrates its 50th anniversary this year. And during all 50 years of its existence, HoG has been a fervent agent of change for the bleeding disorders community, both in its home state and with its…
The New WFH Shared Decision-Making ToolSpeaker: Donna Coffin, WFH Director of Research and EducationLearn about the WFH SDM model designed to enable people with hemophilia to make informed decisions about the management of…
After several decades of preclinical and clinical research, pitfalls and progress, gene therapies for hemophilia A and B have become a reality with recent FDA approvals. While these therapies, along with others still in development, represent both…
National Harbor, MD - July 25, 2023 - The National Hemophilia Foundation (NHF) is thrilled to announce the highly anticipated 2023 Bleeding Disorders Conference, set to take place from August 17-19 at the renowned Gaylord National Resort &…
The National Bleeding Disorders Foundation (formerly the National Hemophilia Foundation) is dedicated to finding cures for inheritable blood and bleeding disorders and to addressing and preventing the complications of these…
Factor up: Discover the Possibility of Higher Factor VIII Levels for Longer
Speaker: Dr. Jonathan Roberts and Joey Smiles
Thanks to Sanofi for their generous support of this webinar presentation.
NHF's…